Last update 06 Jun 2026

Anti-COVID-19 dimeric antigen receptor NK-cell therapy (Sorrento Therapeutics)

Overview

Basic Info

Drug Type
Cell therapy
Synonyms
AntiCOVID19 DARNKcell therapy Sorrento Therapeutics, AntiCOVID2019 DARNKcell therapy Sorrento Therapeutics
Target
SARS-CoV-2 antigen
Action
inhibitors
Mechanism
SARS-CoV-2 antigen inhibitors, Immunologic cytotoxicity, Natural killer cell replacements
Therapeutic Areas
Infectious DiseasesRespiratory Diseases
Active Indication-
Inactive Indication
COVID-19
Originator Organization
Sorrento Therapeutics, Inc.Sorrento Therapeutics, Inc.
Active Organization-
Inactive Organization
Sorrento Therapeutics, Inc.Sorrento Therapeutics, Inc.
License Organization-
Drug Highest PhasePendingPreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with Anti-COVID-19 dimeric antigen receptor NK-cell therapy (Sorrento Therapeutics)
Login to view more data
100 Translational Medicine associated with Anti-COVID-19 dimeric antigen receptor NK-cell therapy (Sorrento Therapeutics)
Login to view more data
100 Patents (Medical) associated with Anti-COVID-19 dimeric antigen receptor NK-cell therapy (Sorrento Therapeutics)
Login to view more data
100 Deals associated with Anti-COVID-19 dimeric antigen receptor NK-cell therapy (Sorrento Therapeutics)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
COVID-19Preclinical
United States
Sorrento Therapeutics, Inc.Sorrento Therapeutics, Inc.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free